Media Center

 

Third Rock News & Events

January 26, 2017 - Third Rock Ventures Names Sarah Larson as Partner
» Read More

October 31, 2016 - Third Rock Ventures Raises $616 Million Fund IV
» Read More

September 24, 2016 - Third Rock Ventures’ Venture Partner Phil Reilly to receive the Henri Termeer Lifetime Achievement Award at the 5th Annual Tribute to Champions of Hope
» Read More

May 23, 2016 - Third Rock Ventures’ Venture Partner Phil Reilly to Speak at MassBio Event to Discuss his New Book “Orphan: The Quest to Save Children with Rare Disease”
» Read More

April 25, 2016 - Third Rock Ventures' Partner, Robert Tepper, to Moderate Panel at the World Medical Innovation Forum
» Read More

April 6, 2016 - Third Rock Ventures' Partner, Cary Pfeffer, to Present at Xconomy's EXOME: What's Hot in Boston Biotech
» Read More

Portfolio News

Ablexis
September 14, 2017 - Ablexis Announces Licensing of the AlivaMab Mouse to Five Prime Therapeutics
» Press Release | Company News

REVOLUTION Medicines
September 14, 2017 - REVOLUTION Medicines Reports Discovery that May Expand Range of Clinically Actionable Cancer Mutations
» Press Release | Company News

bluebird bio
September 13, 2017 - bluebird bio Announces First Patient Treated in Expansion Cohort of CRB-401, Phase 1 Study of Anti-BCMA CAR T Therapy bb2121
» Press Release | Company News

CytomX Therapeutics
September 13, 2017 - CytomX to Present at the Cantor Fitzgerald Healthcare Conference
» Press Release | Company News

Editas Medicine
September 12, 2017 - Editas Medicine Initiates Clinical Natural History Study to Evaluate Patients with Leber Congenital Amaurosis Type 10 (LCA10)
» Press Release | Company News

SAGE Therapeutics
September 12, 2017 - Sage Therapeutics Reports Top-Line Results from Phase 3 STATUS Trial of Brexanolone in Super-Refractory Status Epilepticus
» Press Release | Company News

Zafgen
September 12, 2017 - Zafgen Presents New Preclinical Data on ZGN-1061 at the 53rd Annual Meeting of The European Association For The Study of Diabetes
» Press Release | Company News

Zafgen
September 12, 2017 - Zafgen Initiates Phase 2 Clinical Trial for ZGN-1061 In Patients with Type 2 Diabetes
» Press Release | Company News

Blueprint Medicines
September 10, 2017 - Blueprint Medicines Announces New Data from Ongoing Phase 1 Clinical Trial of BLU-554 in Patients with Advanced Hepatocellular Carcinoma
» Press Release | Company News

Foundation Medicine
September 8, 2017 - Foundation Medicine to Present Validation Data for Its Assay Measuring Tumor Mutational Burden in Blood (bTMB), a New, Non-Invasive Predictor of Response to Immunotherapy
» Press Release | Company News

News Archives